CIBC Private Wealth Group
SRRA

CIBC Private Wealth Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

CIBC Private Wealth Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-231
Closed -$19K – 2137
2018
Q1 		$19K Buy
231
+53
+30% +$6.01K ﹤0.01% 1405
2017
Q4 		$27K Buy
+178
New +$17.1K ﹤0.01% 1346

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIBC Private Wealth Group's SRRA Position: Q2 2018 in Review

CIBC Private Wealth Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2018, closing a stake of 231 shares — an estimated $19K sold.

CIBC Private Wealth Group first reported a position in SRRA in Q4 2017 and held it in 2 quarters. The position peaked at $27K in Q4 2017. 70 funds tracked by Wall St. Rank hold SRRA as of Q2 2018.

  • CIBC Private Wealth Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 231 Sierra Oncology, Inc. Common Stock shares in Q2 2018, an estimated $19K.
  • CIBC Private Wealth Group first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • CIBC Private Wealth Group's Sierra Oncology, Inc. Common Stock position peaked at $27K in Q4 2017.
  • 70 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2018.

Based on CIBC Private Wealth Group's 13F filing for Q2 2018, filed 2 Aug 2018.